WarfarinThrombosisVenous ThrombosisAnticoagulantsVitamin K Epoxide ReductasesCoronary ThrombosisSinus Thrombosis, IntracranialIntracranial ThrombosisThromboembolismCarotid Artery ThrombosisHemorrhageProthrombin TimeAtrial FibrillationVitamin KMixed Function Oxygenasesbeta-AlanineBlood CoagulationPhlebographySagittal Sinus ThrombosisIntracranial Embolism and ThrombosisAryl Hydrocarbon HydroxylasesAspirinHeparin, Low-Molecular-WeightPlatelet Aggregation InhibitorsThrombophiliaFibrinolytic AgentsPharmacogeneticsRodenticidesUpper Extremity Deep Vein ThrombosisIliac VeinFemoral VeinHeparinTreatment OutcomeProthrombinVenous ThromboembolismStrokeRisk FactorsHemostasisAntiphospholipid SyndromeFibrin Fibrinogen Degradation ProductsPortal VeinCerebral VeinsAntithrombinsRetrospective StudiesDrug MonitoringFactor VFollow-Up StudiesCavernous Sinus ThrombosisTime FactorsVena Cava, InferiorVitamin K 1Drug InteractionsPartial Thromboplastin TimeThrombectomyProspective StudiesEmbolismProtein S DeficiencyAcenocoumarolIntracranial HemorrhagesStentsAntibodies, AntiphospholipidLateral Sinus ThrombosisBleeding TimePopliteal VeinPlatelet AggregationCatheterization, Central VenousAdministration, OralDrug Dosage CalculationsRecurrence4-HydroxycoumarinsBenzimidazolesMesenteric VeinsTiclopidineSubclavian VeinBlood Coagulation FactorsBlood Coagulation DisordersDrug-Eluting StentsLupus Coagulation InhibitorEnoxaparinThromboplastinPlatelet ActivationDose-Response Relationship, DrugBlood Coagulation TestsJugular VeinsBlood PlateletsProtein CThrombolytic TherapyAntithrombin III DeficiencyUltrasonography, Doppler, DuplexProtein C DeficiencyCranial SinusesRisk AssessmentActivated Protein C ResistanceGraft Occlusion, VascularBudd-Chiari SyndromeHeart Valve ProsthesisHerb-Drug InteractionsIncidenceRenal VeinsFibrinogen